• Citer

Intravenous Lacosamide in Refractory Seizure Clusters and Status Epilepticus: Comparison of 200 and 400 mg Loading Doses.

par Legros, Benjamin ;Depondt, Chantal ;Levy Nogueira, Marcel ;Ligot, Noemie ;Mavroudakis, Nicolas ;Naeije, Gilles ;Gaspard, Nicolas
Référence Neurocritical care
Publication Publié, 2013-07

Article révisé par les pairs

• Détails
• Contenu

Résumé :

The treatment of refractory status epilepticus (RSE) remains largely empirical. Lacosamide (LCM) is a new anticonvulsant available in intravenous (IV) form, but its optimal dosing regimen for the treatment of RSE is unknown. We compared safety and efficacy of two loading doses: 200 and 400 mg.